The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes
Open accessAbstract
Smoking is a major risk factor for osteoporosis and fracture, but the mechanism through which smoke causes bone loss remains unclear. Here, we show that the smoke toxins benzo( a )pyrene (BaP) and 2,3,7,8-tetrachlorodibenzo- p -dioxin (TCDD) interact with the aryl hydrocarbon receptor (Ahr) to induce osteoclastic bone resorption through the activation of cytochrome P450 1a/1b (Cyp1) enzymes. BaP and TCDD enhanced osteoclast formation in bone marrow cell cultures and gavage with BaP stimulated bone resorption and osteoclastogenesis in vivo. The osteoclastogenesis triggered by BaP or RANK-L was reduced in Ahr −/− cells, consistent with the high bone mass noted in Ahr −/− male mice. The receptor activator of NF-κB ligand (RANK-L) also failed to induce the expression of Cyp1 enzymes in Ahr −/− cells. Furthermore, the osteoclastogenesis induced by TCDD was lower in Cyp1a1/1a2 −/− and Cyp1a1/1a2/1b1 −/− cultures, indicating that Ahr was upstream of the Cyp enzymes. Likewise, the pharmacological inhibition of the Cyp1 enzymes with tetramethylsilane or proadifen reduced osteoclastogenesis. Finally, deletion of the Cyp1a1 , Cyp1a2 , and Cyp1b1 in triple knockout mice resulted in reduced bone resorption and recapitulated the high bone mass phenotype of Ahr −/− mice. Overall, the data identify the Ahr and Cyp1 enzymes not only in the pathophysiology of smoke-induced osteoporosis, but also as potential targets for selective modulation by new therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, TCDD administration was unable to stimulate osteoclastogenesis in bone marrow macrophages (BMMs) from CYP1A1/CYP1A2 double knockout and CYP1A1/CYP1A2/CYP1B1 triple knockout mice, unlike in BMM from wild-type mice [33].”
From An Overlooked Bone Metabolic Disorder: Cigarette Smoking-Induced Osteoporosis (2022) · cites this paper as [33]
In the citing paper
“Jameel et al. reported that BaP and TCDD in cigarette smoke caused AhR activation and a significant increase in CYP1A1 and CYP1A2 expression, resulting in enhanced OC differentiation and compromised bone mass in wild-type mice but not in AhR-/- mice [33].”
From An Overlooked Bone Metabolic Disorder: Cigarette Smoking-Induced Osteoporosis (2022) · cites this paper as [33]
Citations
Cites
Skeletal remodeling in health and disease
Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069
Self-citationSmoking and fracture risk: a meta-analysis
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., De Laet, C., Eisman, J. A., Fujiwara, S., Kroger, H., McCloskey, E. V., Mellstrom, D., et al. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1640-3 · Cited by 999
FSH Directly Regulates Bone Mass
Sun, L., Peng, Y., Sharrow, A. C., Iqbal, J., Zhang, Z., Papachristou, D. J., Zaidi, S., Zhu, L.-L., Yaroslavskiy, B. B., Zhou, H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.051 · Cited by 723 · cited 9×
“Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes Jameel Iqbala,b,c, Li Sunc, Jay Caod, Tony Yuenc, Ping Luc, Itai Babe, N. Adrian Leua, Satish Srinivasana, Sagie Wagagef, Christopher A. Hunterf, Daniel W. Nebertg, Mone Zaidic,1,2, and Narayan G. Avadhania,1,2 Depart…”
MethodInfluentialSelf-citationTSH Is a Negative Regulator of Skeletal Remodeling
Abe, E., Marians, R. C., Yu, W., Wu, X.-B., Ando, T., Li, Y., Iqbal, J., Eldeiry, L., Rajendren, G., Blair, H. C., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00771-2 · Cited by 691
Self-citationCytochrome P450-mediated metabolism of estrogens and its regulation in human
Tsuchiya, Y., Nakajima, M., & Yokoi, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.10.007 · Cited by 616
A meta-analysis of the effects of cigarette smoking on bone mineral density
Ward, K. D., & Klesges, R. C. (2001) · Calcified Tissue International · doi:10.1007/bf02390832 · Cited by 530
Human cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
Self-citationChapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens
Jefcoate, C. R. E., Liehr, J. G., Santen, R. J., Sutter, T. R., Yager, J. D., Yue, W., Santner, S. J., TEKMAL, R. R., Demers, L. M., Pauley, R. J., et al. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024248 · Cited by 260
Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development
Bruno, R. D., & Njar, V. C. O. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.05.046 · Cited by 255
Uno, S., Dalton, T. P., Dragin, N., Curran, C. P., Derkenne, S., Miller, M. L., Shertzer, H. G., Gonzalez, F. J., & Nebert, D. W. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.021501 · Cited by 227
Self-citationA new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-κB family
Vogel, C. F. A., & Matsumura, F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.036 · Cited by 202
Nebert, D. W., & Karp, C. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800053200 · Cited by 165
Self-citationSissung, T. M., Price, D. K., Sparreboom, A., & Figg, W. D. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0101 · Cited by 152
Singh, S., Casper, R., Fritz, P., Sukhu, B. D., Ganss, B., Girard, B., Savouret, J., & Tenenbaum, H. C. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670183 · Cited by 146
Increased Bone Resorption in Moderate Smokers with Low Body Weight: The Minos Study
Szulc, P. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.666 · Cited by 144
Smoking and bone metabolism in elderly women
Rapuri, P. B., Gallagher, J. C., Balhorn, K. E., & Ryschon, K. L. (2000) · Bone · doi:10.1016/s8756-3282(00)00341-0 · Cited by 132
Lees, R. L., Sabharwal, V. K., & Heersche, J. N. M. (2001) · Bone · doi:10.1016/s8756-3282(00)00433-6 · Cited by 113
Global Economic and Health Benefits of Tobacco Control: Part 1
Wipfli, H. L., & Samet, J. M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.93 · Cited by 103
High Levels of Dioxin-Like Potential in Cigarette Smoke Evidenced byIn vitroandIn vivoBiosensing
Kasai, A., Hiramatsu, N., Hayakawa, K., Yao, J. Q., Maeda, S., & Kitamura, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4541 · Cited by 93
The Evolving Role of the Aryl Hydrocarbon Receptor (AHR) in the Normophysiology of Hematopoiesis
Lindsey, S. C., & Papoutsakis, E. T. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9384-5 · Cited by 80
Galván, N., TESKE, D., Zhou, G.-D., Moorthy, B., MacWilliams, P. S., Czuprynski, C. J., & Jefcoate, C. R. E. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.06.026 · Cited by 76
Vogel, C. F. A., Li, W., Wu, D., Miller, J. K., Sweeney, C. A., Lazennec, G., Fujisawa, Y., & Matsumura, F. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.05.011 · Cited by 68
Yin, X., Chen, J., Mao, W., Wang, Y., & Chen, M. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-46 · Cited by 67
Voronov, I., Heersche, J. N. M., Casper, R. F., Tenenbaum, H. C., & Manolson, M. F. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.028 · Cited by 64
Phenotype of the Cyp1a1/1a2/1b1(-/-) Triple-Knockout Mouse
Dragin, N., Shi, Z., Madan, R., Karp, C. L., Sartor, M. A., Chen, C., Gonzalez, F. J., & Nebert, D. W. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045658 · Cited by 64
Self-citationDiNatale, B. C., Schroeder, J. C., & Perdew, G. H. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20702 · Cited by 63
Kung, M. H., Yukata, K., O’Keefe, R. J., & Zuscik, M. J. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22819 · Cited by 57
Benzo[a]pyrene inhibits osteoclastogenesis by affecting RANKL-induced activation of NF-κB
Voronov, I., Li, K., Tenenbaum, H. C., & Manolson, M. F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.02.025 · Cited by 57
Galván, N., Jaskula‐Sztul, R., MacWilliams, P. S., Czuprynski, C. J., & Jefcoate, C. R. E. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00338-7 · Cited by 53
Labrecque, M. P., Takhar, M., Hollingshead, B. D., Préfontaine, G. G., Perdew, G. H., & Beischlag, T. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029545 · Cited by 50
Naruse, M., Otsuka, E., Naruse, M., Ishihara, Y., Miyagawa‐Tomita, S., & Hagiwara, H. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.038 · Cited by 41
Wejheden, C., Brunnberg, S., Larsson, S., Lind, P. M., Andersson, G. N., & Hanberg, A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp284 · Cited by 41
Ilvesaro, J. M., Pohjanvirta, R., Tuomisto, J., Viluksela, M., & Tuukkanen, J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.01.027 · Cited by 39
Targeting Cytochrome P450 Enzymes: A New Approach in Anticancer Drug Development
Bruno, R. D., & Njar, V. C. O. (2007) · ChemInform · doi:10.1002/chin.200739257 · Cited by 38
The Tissue Selective Estrogen Complex: A Novel Approach to the Treatment of Menopausal Symptoms
Kagan, R. (2012) · Journal of Women s Health · doi:10.1089/jwh.2011.3448 · Cited by 29
N′jai, A. U., Larsen, M. C., Bushkofsky, J. R., Czuprynski, C. J., & Jefcoate, C. R. E. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070631 · Cited by 19
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1210/jcem.87.2.8232 · DOI · Paper page
Cited by
Sorted by citations
Nebert, D. W. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.06.001 · Cited by 286
Self-citationClinical importance of IL-22 cascade in IBD
Mizoguchi, A., Yano, A., Himuro, H., Ezaki, Y., Sadanaga, T., & Mizoguchi, E. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1401-7 · Cited by 226
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
Huang, Y.-S., Ogbechi, J., Clanchy, F. I., Williams, R. O., & Stone, T. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00388 · Cited by 187
Guengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 159
Grishanova, A. Y., & Perepechaeva, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126719 · Cited by 130
Metadata
- Authors
- Iqbal, J., Sun, L., Cao, J., Yuen, T., Lu, P., Bab, I., Leu, N. A., Srinivasan, S., Wagage, S., Hunter, C. A., Nebert, D. W., Zaidi, M., & Avadhani, N. G.
- Affiliations
- University of Pennsylvania (US)
- Icahn School of Medicine at Mount Sinai (US)
- United States Department of Agriculture (US)
- The Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, NY 10029;
- Hebrew University of Jerusalem (IL)
- Departments of aAnimal Biology and
- Pathobiology, School of Veterinary Medicine, and
- University of Cincinnati Medical Center (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-06-17
- Volume
- 110
- Issue
- 27
- Pages
- 11115-11120
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3704019
- OpenAlex
- W2079795497
- Cited by
- 126
- References
- 36
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 6 · 2023: 8 · 2022: 12 · 2021: 8 · 2020: 15 · 2019: 8 · 2018: 12 · 2017: 10 · 2016: 6 · 2015: 11 · 2014: 14 · 2013: 1
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG040132, AG-23176, AG40132, R01AG023176)
- National Cancer Institute (CA22763, P30CA016520)
- National Institute of General Medical Sciences (R01GM034883, GM 34883)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK80459, R01DK080459)
- National Institute of Environmental Health Sciences (ES014403, P30ES006096, R01ES008147, R01ES014403, P30 ES-06096, ES-08147)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- smoking, osteoporosis, bone loss, aryl hydrocarbon receptor, benzo[a]pyrene, TCDD, osteoclastogenesis, bone resorption, RANKL, tetramethylsilane, proadifen, bone mass
- MeSH terms
- Polychlorinated Dibenzodioxins, Animals, Aryl Hydrocarbon Hydroxylases, Benzo(a)pyrene, Bone Resorption, Carcinogens, Disease Models, Animal, Enzyme Induction, Female, Humans, Male, Mice, Inbred C57BL, Smoke, Smoking, Nicotiana, Receptors, Aryl Hydrocarbon, Mice, Knockout, Cytochrome P-450 CYP1A1, Cytochrome P-450 CYP1A2, Mice, Cytochrome P-450 CYP1B1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
